Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People who used cholesterol-lowering medications had a 40% lower risk for liver disease progression.
Use of cholesterol-lowering medications was also associated with reduced mortality from liver cancer and other causes.
That’s the core message of an essay by Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.
Researchers analyzed cancer outcomes among a large group of South Koreans with hepatitis B virus.
Given to those with polycystic kidney and liver diseases, the injectable drug reduced the volume of swollen livers.
Protease inhibitors, including those used for hep C, and various other drugs may cause drug-drug interactions with statins.
Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston
A major randomized, double-blind study pitted Livalo (pitavastatin) against Pravachol (pravastatin).
On the flip side, a recent study found that hep C treatment was associated with rising cholesterol.
The benefit is seen among with those with normal ALT levels, an indicator of liver health.
Medications sometimes prescribed to help manage high cholesterol levels also show promise as add-on treatments for hepatitis C
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.